Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CDT Equity Inc. - Common Stock (NQ:CDT)

1.355 +0.335 (+32.84%)
Streaming Delayed Price Updated: 3:47 PM EDT, Jun 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CDT Equity Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Levi Strauss Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Why Is Conduit Pharmaceuticals (CDT) Stock Up 12% Today? ↗
Conduit Pharmaceuticals stock is up on Wednesday alongside heavy trading following an invest update on CDT shares. 
Via InvestorPlace
News headline image
Why Is Conduit Pharmaceuticals (CDT) Stock Up 123% Today? ↗
Conduit Pharmaceuticals stock is up on Thursday with heavy trading of CDT shares after the company announce a new license agreement. 
Via InvestorPlace
News headline image
Why Zhibao Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
From Conduit Pharmaceuticals
Via GlobeNewswire
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
Pre-market stock movers are a hot topic on Wednesday and we have all of the biggest stories traders need to know about this morning! 
Via InvestorPlace
News headline image
Why Serve Robotics Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
CDT Stock Earnings: Conduit Pharmaceuticals Reported Results for Q2 2024 ↗
Conduit Pharmaceuticals just reported results for the second quarter of 2024. 
Via InvestorPlace
News headline image
Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders
From Conduit Pharmaceuticals
Via GlobeNewswire
News headline image
S&P 500 Gains 1%; US Jobless Claims Fall To 230,000 ↗
 
Via Benzinga
Topics Stocks
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
It's time to dive into the biggest pre-market stock movers on Thursday morning with all of the latest news this morning! 
Via InvestorPlace
News headline image
Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments
From Conduit Pharmaceuticals
Via GlobeNewswire
News headline image
EXCLUSIVE: Penny Stock Conduit Pharmaceuticals Inks Licensing Pact With AstraZeneca For Multiple Assets ↗
Conduit Pharmaceuticals has entered an exclusive licensing agreement with AstraZeneca to develop AZD1656, AZD5658, and AZD5904, targeting autoimmune disorders and idiopathic male infertility. Conduit... 
Via Benzinga
News headline image
Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
What Happened With Conduit Pharmaceuticals (CDT) Stock Today? ↗
Conduit Pharmaceuticals shares traded higher by over 50% early Tuesday. The company announced it received patent approval for its lead asset targeting autoimmune diseases. 
Via Benzinga
Topics Intellectual Property
News headline image
Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
Why Is Greenpro Capital (GRNQ) Stock Down 19% Today? ↗
Greenpro Capital stock is down on Tuesday after shares of GRNQ underwent a major rally Monday with the announcement of a strategic alliance. 
Via InvestorPlace
News headline image
Why Is Autonomix Medical (AMIX) Stock Down 17% Today? ↗
Autonomix Medical stock is down on Tuesday but that's only due to AMIX shares coming off of a massive 130% rally on Monday. 
Via InvestorPlace
News headline image
Why Is Conduit Pharmaceuticals (CDT) Stock Up 73% Today? ↗
Conduit Pharmaceuticals stock is up with heavy trading of CDT shares on Tuesday after the company secured a new patent in Australia. 
Via InvestorPlace
Topics Intellectual Property
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
It's time to dive into the biggest pre-market stock movers as we check out all of the latest news worth reading about on Tuesday morning! 
Via InvestorPlace
News headline image
Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
Composition of matter patent approval underscores the Company’s solid-form technology to maximize future value and ability to strengthen and broaden its intellectual property portfolio 
From Conduit Pharmaceuticals
Via GlobeNewswire
News headline image
Why Match Group Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Conduit Pharmaceuticals to Join Russell 3000® Index
From Conduit Pharmaceuticals
Via GlobeNewswire
News headline image
A Presidio Property Trust Major Investment To Be Part of Russell 2000®
From Presidio Property Trust, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.